Oxygenta Pharmaceutical Reaches All-Time High Stock Price, Outperforms Sector and Market
Oxygenta Pharmaceutical, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high of Rs.89.17 on October 14th, 2024. The stock has outperformed the sector by 1.97% and is currently trading above its moving averages, indicating a positive trend. Investors are advised to conduct their own research before making any investment decisions.
Oxygenta Pharmaceutical, a microcap pharmaceutical company, has recently reached an all-time high stock price of Rs.89.17 on October 14th, 2024. This news comes as the stock has been gaining for the past 16 days, with a consecutive gain of 81.98% in that period. The stock has also outperformed the sector by 1.97% today.
According to MarketsMOJO, a leading stock market analysis and research platform, the stock call for Oxygenta Pharmaceutical is 'Hold'. This is based on the company's performance in the past year, where it has seen a 199.83% increase in stock price, compared to the Sensex's 23.40% performance.
Oxygenta Pharmaceutical is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance. This is a promising sign for investors and reflects the company's strong financials and growth potential.
As a microcap company in the pharmaceutical industry, Oxygenta Pharmaceutical has shown impressive growth and potential in the past year. However, it is important to note that this article is based on factual information and does not include any external data or sources. Investors are advised to conduct their own research and analysis before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
